Wei Liu
About Wei Liu
Wei Liu is a Director at 百时美施贵宝 in 上海, with extensive experience in clinical research and the pharmaceutical industry, specializing in Immunology and Gastrointestinal therapeutic areas.
Current Roles and Responsibilities
Wei Liu holds multiple key positions in prominent pharmaceutical companies in Shanghai. As a Director at 百时美施贵宝, Wei leads significant initiatives within the company. Concurrently, Wei serves as a Sr. Manager at 优时比, managing critical projects. Additionally, as a Sr. Medical Manager and Clinical Research Physician at Lilly, Wei plays a pivotal role in advancing clinical research.
Previous Experience at Pfizer
Wei Liu worked at Pfizer as a Medical Advisor from 2010 to 2011. During the 9-month tenure, Wei provided medical expertise and helped guide the company's medical strategies and practices.
Clinical Practice at Shanghai Ruijin Hospital
From 2006 to 2010, Wei Liu served as an Attending Physician at Shanghai Ruijin Hospital. In this role, Wei focused on pediatric gastroenterology, providing critical care and treatment to young patients. This experience laid a strong foundation for Wei's subsequent career in clinical research and the pharmaceutical industry.
Educational Background in Medicine
Wei Liu has an extensive educational background in medicine. Wei earned a Doctor of Medicine (M.D.) degree from the School of Medicine, Shanghai Jiaotong University, specializing in Pediatric gastroenterology, from 2003 to 2006. Prior to that, Wei achieved a Master's Degree in Pediatric gastroenterology from Shanghai Second Medical University from 2000 to 2003. Additionally, Wei holds a Bachelor's Degree in Clinical Medicine from Jining Medical College, earned from 1994 to 1999.
Specialization and Leadership in Therapeutic Areas
Since 2017, Wei Liu has been leading the Gastrointestinal (GI) therapeutic area in clinical research. During this period, Wei has specialized in Immunology, providing expert leadership and guidance in these areas. With over 6 years of experience in director-level roles, Wei has developed a strong track record in managing and advancing therapeutic research.